Neurotoxins distinguish between different neuronal nicotinic acetylcholine receptor subunit combinations. 1990

C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
Division of Neuroscience, Baylor College of Medicine, Houston, Texas 77030.

Neuronal and muscle nicotinic acetylcholine receptor subunit combinations expressed in Xenopus oocytes were tested for sensitivity to various neurotoxins. Extensive blockade of the alpha 3 beta 2 neuronal subunit combination was achieved by 10 nM neuronal bungarotoxin. Partial blockade of the alpha 4 beta 2 neuronal and alpha 1 beta 1 gamma delta muscle subunit combinations was caused by 1,000 nM neuronal bungarotoxin. The alpha 2 beta 2 neuronal subunit combination was insensitive to 1,000 nM neuronal bungarotoxin. Nearly complete blockade of all neuronal subunit combinations resulted from incubation with 2 nM neosurugatoxin, whereas 200 nM neosurugatoxin was required for partial blockade of the alpha 1 beta 1 gamma delta muscle subunit combination. The alpha 2 beta 2 and alpha 3 beta 2 neuronal subunit combinations were partially blocked by 10,000 nM lophotoxin analog-1, whereas complete blockade of the alpha 4 beta 2 neuronal and alpha 1 beta 1 gamma delta muscle subunit combinations resulted from incubation with this concentration of lophotoxin analog-1. The alpha 1 beta 1 gamma delta muscle subunit combination was blocked by the alpha-conotoxins G1A and M1 at concentrations of 100 nM. All of the neuronal subunit combinations were insensitive to 10,000 nM of both alpha-conotoxins. Thus, neosurugatoxin and the alpha-conotoxins distinguish between muscle and neuronal subunit combinations, whereas neuronal bungarotoxin and lophotoxin analog-1 distinguish between different neuronal subunit combinations on the basis of differing alpha subunits.

UI MeSH Term Description Entries
D008978 Mollusk Venoms Venoms from mollusks, including CONUS and OCTOPUS species. The venoms contain proteins, enzymes, choline derivatives, slow-reacting substances, and several characterized polypeptide toxins that affect the nervous system. Mollusk venoms include cephalotoxin, venerupin, maculotoxin, surugatoxin, conotoxins, and murexine. Conus Venoms,Octopus Venoms,Snail Venoms,Conus Venom,Mollusc Venoms,Mollusk Venom,Octopus Venom,Snail Venom,Venom, Conus,Venom, Mollusk,Venom, Octopus,Venom, Snail,Venoms, Conus,Venoms, Mollusc,Venoms, Mollusk,Venoms, Octopus,Venoms, Snail
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D009498 Neurotoxins Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. Alpha-Neurotoxin,Excitatory Neurotoxin,Excitotoxins,Myotoxin,Myotoxins,Neurotoxin,Alpha-Neurotoxins,Excitatory Neurotoxins,Excitotoxin,Alpha Neurotoxin,Alpha Neurotoxins,Neurotoxin, Excitatory,Neurotoxins, Excitatory
D009865 Oocytes Female germ cells derived from OOGONIA and termed OOCYTES when they enter MEIOSIS. The primary oocytes begin meiosis but are arrested at the diplotene state until OVULATION at PUBERTY to give rise to haploid secondary oocytes or ova (OVUM). Ovocytes,Oocyte,Ovocyte
D010456 Peptides, Cyclic Peptides whose amino acid residues are linked together forming a circular chain. Some of them are ANTI-INFECTIVE AGENTS; some are biosynthesized non-ribosomally (PEPTIDE BIOSYNTHESIS, NON-RIBOSOMAL). Circular Peptide,Cyclic Peptide,Cyclic Peptides,Cyclopeptide,Orbitide,Circular Peptides,Cyclopeptides,Orbitides,Peptide, Circular,Peptide, Cyclic,Peptides, Circular
D011978 Receptors, Nicotinic One of the two major classes of cholinergic receptors. Nicotinic receptors were originally distinguished by their preference for NICOTINE over MUSCARINE. They are generally divided into muscle-type and neuronal-type (previously ganglionic) based on pharmacology, and subunit composition of the receptors. Nicotinic Acetylcholine Receptors,Nicotinic Receptors,Nicotinic Acetylcholine Receptor,Nicotinic Receptor,Acetylcholine Receptor, Nicotinic,Acetylcholine Receptors, Nicotinic,Receptor, Nicotinic,Receptor, Nicotinic Acetylcholine,Receptors, Nicotinic Acetylcholine
D002038 Bungarotoxins Neurotoxic proteins from the venom of the banded or Formosan krait (Bungarus multicinctus, an elapid snake). alpha-Bungarotoxin blocks nicotinic acetylcholine receptors and has been used to isolate and study them; beta- and gamma-bungarotoxins act presynaptically causing acetylcholine release and depletion. Both alpha and beta forms have been characterized, the alpha being similar to the large, long or Type II neurotoxins from other elapid venoms. alpha-Bungarotoxin,beta-Bungarotoxin,kappa-Bungarotoxin,alpha Bungarotoxin,beta Bungarotoxin,kappa Bungarotoxin
D003064 Cnidarian Venoms Venoms from jellyfish; CORALS; SEA ANEMONES; etc. They contain hemo-, cardio-, dermo- , and neuro-toxic substances and probably ENZYMES. They include palytoxin, sarcophine, and anthopleurine. Chironex Venoms,Jellyfish Venoms,Nematocyst Venoms,Sea Anemone Venoms,Chironex Venom,Cnidarian Venom,Jellyfish Venom,Portuguese Man-of-War Venom,Sea Anemone Venom,Portuguese Man of War Venom,Venom, Chironex,Venom, Cnidarian,Venom, Jellyfish,Venom, Portuguese Man-of-War,Venom, Sea Anemone,Venoms, Chironex,Venoms, Cnidarian,Venoms, Jellyfish,Venoms, Nematocyst,Venoms, Sea Anemone
D005260 Female Females
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
October 1989, Biochemistry,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
April 1999, The Journal of biological chemistry,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
March 1989, Journal of neurochemistry,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
August 1995, Cellular and molecular neurobiology,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
July 2002, The Journal of physiology,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
March 1991, Nature,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
January 1992, NIDA research monograph,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
February 1998, The Journal of pharmacology and experimental therapeutics,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
August 1992, Genomics,
C W Luetje, and K Wada, and S Rogers, and S N Abramson, and K Tsuji, and S Heinemann, and J Patrick
March 2002, The Journal of comparative neurology,
Copied contents to your clipboard!